Abstract. Immature oligodendrocytes (OLs) derive from a large pool of late OL progenitors that populate human cerebral white matter throughout the latter half of gestation. We recently reported that a minor population of immature OLs are present in human cerebral white matter for at least 3 months before these cells commit to myelinogenesis around 30 wk postconceptional age. Since this finding supports dissociation between the events that regulate human immature OL maturation and their commitment to myelinogenesis, we characterized here the cellular sequence of events that characterize immature OLs during the transition from a premyelinating to a myelinating state. Commitment of immature OLs to myelinogenesis in human cerebral white matter correlated with the longitudinal extension of specialized processes, designated ''pioneer processes,'' that made multiple types of apparent contacts with axons. This event coincided with the appearance of 3 distinct populations of sheaths that varied in their labeling for myelin basic protein (MBP). Since few axons initially labeled for MBP, this supported the occurrence in vivo of O4-negative, O1-positive premyelin sheaths that precede MBP-positive compacted myelin. These observations identify 3 sequential stages of early myelinogenesis: 1) the initial ensheathment of axons by premyelin sheaths generated by immature OLs; 2) the initial insertion of MBP into transitional sheaths; and 3) the generation of MBP-rich mature myelin.
INTRODUCTION
Although much is known about the biochemical and molecular events of human myelinogenesis (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , further definition of the cellular events is needed to better understand myelin disorders that arise during fetal white matter development. Of particular interest is periventricular leukomalacia (PVL), the leading cause of brain injury in premature infants, and the underlying cause of cerebral palsy and cognitive impairment in survivors of the newborn critical care nursery (12) . The major pathological feature of PVL is a chronic disturbance of cerebral myelination, a finding that suggests that late OL progenitors are a cellular target of ischemic injury in PVL (13) . We recently reported that the timing of appearance of late OL progenitors in human cerebral white matter coincides with the high risk period for PVL (14) . Longterm survivors with PVL have deficient myelin volume on brain imaging and delayed myelination at autopsy (15) (16) (17) (18) .
Human fetal myelinogenesis is preceded by the appearance of numerous ''myelination glia'' that are hypothesized to be OL precursors (19) . These cells appear to be clinically important, because they were conspicuously reduced in number in the cerebral white matter of preterm infants with PVL (15) . We recently used markers specific to the OL lineage to define OL lineage progression in human parietal white matter, a region of high predilection for PVL (14) . We identified 2 major periods in human cerebral white matter development during the latter half of gestation. Between 18 and 27 wk postconceptional age, late OL progenitors were the major OL stage in the white matter. Late OL progenitors (preOLs) labeled with the O4 monoclonal antibody and for the chondroitin sulfate proteoglycan, NG2, but not with the O1 monoclonal antibody. By means of the O4 and O1 antibodies, O4ϩO1Ϫ preOLs were distinguished from a minor population of O4ϩO1ϩ immature OLs. These immature OLs comprised approximately 10% of all OL lineage cells in the white matter between 18 and 27 wk. OL lineage maturation occurred between 28 and 41 wk. An increase in the number of immature OLs began at 28 wk and coincided with the appearance of myelin sheaths in the periventricular white matter that labeled for MBP. Between 28 and 41 wk, the percentage of immature OLs increased approximately 3-fold. Hence, in contrast to rodents and birds, where the timing of appearance of immature OLs closely coincides with the onset of myelination (20) (21) (22) (23) , there is a prolonged period of at least 3 months when immature OLs are present but do not initiate myelination. We were thus motivated in the present study to characterize the cellular sequence of events that occur when human immature OLs transition from a premyelinating to a myelinating cell in parietal white matter. Such information may be relevant to the pathogenesis of the myelination disturbances of PVL (24) .
The concept that myelination proceeds from the initial loose wrappings of the axon to a progressively more compacted myelin sheath largely derives from ultrastructural studies in postnatal animals (25) . The mature myelin sheath is widely defined by the presence of myelin basic protein (MBP) (11, (26) (27) (28) (29) . MBP plays a major role in myelin compaction (30, 31) , but little is known about the cellular sequence of events that is involved with the initial stages of human axon ensheathment prior to MBP incorporation to generate the mature myelin sheath. Previous in vitro studies in rodents found that immature OLs generate galactolipid-rich sheets that bind the O4 and O1 antibodies, but not MBP, and precede the insertion of MBP into mature myelin-like sheets (32) . The existence of such ''premyelin'' sheaths that precede the synthesis of mature compacted myelin has not been demonstrated in vivo in humans or animals. We, thus, examined whether the immature OL can generate premyelin sheaths in vivo in human parietal white matter. We hypothesized that such sheaths should label with the O4 and O1 monoclonal antibodies but not for MBP.
We report here that human immature OLs reside in parietal white matter for at least 3 months before they elaborate specialized processes that initiate axonal contact. Individual OL processes exhibited several distinct types of appositions with axons as defined by confocal laser microscopy. Early myelination was initiated by the ensheathment of axons by O4, O1-positive but MBP-negative sheaths generated by immature OLs. We designated these ''premyelin sheaths,'' and this event preceded the insertion of MBP to form mature myelin.
MATERIALS AND METHODS

Clinicopathologic Cases
We studied a standardized region of parietal white matter at the level of the trigone of the lateral ventricle in 23 autopsied cases. The brains were collected from the Department of Pathology at Children's Hospital, (Boston, MA) Brigham and Women's Hospital, Boston, Oregon Health Sciences University (Portland, OR), and the NIH Developmental Brain and Tissue Bank, University of Miami, (Miami, FL). The gestational ages of the fetuses were assessed by foot length. Age was expressed in postconceptional weeks (gestational age plus postnatal) weeks.
Tissue Preparation and Processing
Tissue was immersed at the time of collection in ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer and stored at 2-4ЊC until the time of analysis. Tissue blocks were adhered to a metallic stage, chilled on ice, and embedded in 1% low-gelling temperature agarose (type VII, Sigma, A-4018). Free-floating sections (50 m) were cut in ice-cold PBS on a Leica VTS 1000 vibrating microtome.
Primary Antibodies
The O4 and O1 mouse monocloncal antibodies (20) were isolated and purified by ammonium sulfate fractionation from the media of cultured hybridoma cells (33) that were the generous gift of Dr. Steven Pfeiffer (University of Connecticut Health Center, Farmington, CT). The neat concentration of undiluted O4 was 11.3 mg/ml and of O1 was 3.8 mg/ml. The panaxonal neurofilament marker SMI 312 and the anti-myelin basic protein antibody SMI 99 were mouse monoclonal antibodies from Sternberger Monoclonals Inc. (Lutherville, MD). SMI 99 binds to all 3 isoforms of human MBP.
Immunohistochemistry for O4 and O1 Antibodies
Tissue sections were processed at room temperature (RT; 20ЊC) unless otherwise indicated. All washes were 10 min in a minimum of 5 ml of PBS. For single immunofluorescent labeling, tissue sections were incubated for 1 hour (h) in blocking buffer (5% NGS in PBS), followed by overnight incubation at 2-4ЊC with O4 or O1 (1:1,000 in PBS with 3% NGS). Primary antibody was visualized with a mu-chain specific fluoresceinconjugated IgM secondary antibody (1:100 in PBS with 3%NGS) from Vector Labs (FI-2020; Burlingame, CA). Sections were washed, mounted immediately on chrome-alum subbed microscope slides, air-dried, and stored at 2-4ЊC with desiccant in light-tight boxes.
For double immunofluorescent labeling with O4 and O1, a biotinylated O4 antibody (bO4) was synthesized (Research Genetics, Huntsville, AL), because both primary antibodies are of the same class (IgM). Tissue sections were incubated in blocking buffer for 1 h, followed by overnight incubation at 2-4ЊC with O1 (1:250). Sections were washed and incubated for 2 h at RT in fluorescein-conjugated IgM secondary antibody (1: 100). Sections were washed and incubated overnight at 2-4ЊC with bO4 (1:100). Sections were washed and incubated for 2 h with rhodamine red X-conjugated streptavidin (1:400 in PBS; 016-290-084, Jackson ImmunoResearch Laboratories, West Grove, PA), washed again, and mounted immediately. Immunocytochemical controls confirmed that biotinylation of O4 did not alter the specificity of the antibody, and there was no difference in the morphology or regional distribution of cellular elements labeled with either the native O4 antibody or bO4 (14) .
Immunofluorescence Double-Labeling for O4 or O1
Antibodies and SMI 99
Tissue sections were incubated for 1 h in blocking buffer (5% NGS in PBS), followed by overnight incubation at 2-4ЊC with O4 or O1 (1:1000 in PBS with 3% NGS). Sections were washed 4ϫ in PBS. Sections were incubated for 5 min in ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4 and immediately washed 3ϫ in PBS at RT. Tissue was incubated for 2 h with fluorescein-conjugated IgM secondary antibody (1: 100; Vector Labs) and washed 4ϫ in PBS. For all subsequent steps sections were protected from ambient light. Tissue sections were again incubated in blocking buffer for 1 h, followed by overnight incubation at 2-4ЊC with SMI 99 diluted to 1: 1,000 in PBS with 3% NGS and 0.1% Triton X-100. Sections were washed 4ϫ in PBS and incubated for 2 h with F c fragment-specific rhodamine red X-conjugated anti-mouse IgG (1: 100 in PBS with 3%NGS and 0.1% Triton X-100; 115-295-071, Jackson ImmunoResearch Laboratories).
Immunocytochemical controls, processed under conditions identical to those described above, revealed no cross-reactivity between O4 and the F c fragment-specific rhodamine red X-conjugated anti-mouse IgG. With omission of both primary antibodies, there was no detectable nonspecific labeling with either secondary antibody. It should be noted that the 5-min incubation in 4% paraformaldehyde was required to prevent the solubilization of the O4-antigen complex in the presence of 0.1% Triton X-100. All O4 labeling was otherwise lost in the presence of detergent, which was required for optimal visualization of MBP labeling.
Several conditions of antigen retrieval were tested to optimize the detection of SMI 99 in human fetal cerebral white matter. Free-floating sections were treated with microwave in 10 mM sodium citrate buffer, pH 6.0, followed by 30 min in 10% Triton X-100 in PBS, as previously described (34) . Freefloating sections were also treated for 30 min in 50 mM sodium citrate buffer, pH 9.0 at 80ЊC (35) . These standard methods of antigen retrieval appeared to increase the intensity of SMI 99 immunoreactivity but there was no apparent change in the number or distribution of MBP-positive myelin sheaths relative to untreated sections.
Antibodies and SMI 312
The protocol for single labeling for O4 or O1 (see above) was modified such that the O4 or O1 antibody was co-incubated with SMI 312 (1:1000) overnight at 2-4ЊC in PBS with 3% NGS. SMI 312 was visualized with F c fragment-specific rhodamine red X-conjugated anti-mouse IgG (Jackson ImmunoResearch Laboratories).
Confocal Microscopy
Tissue sections were analyzed with a laser scanning confocal microscope (Noran Instruments, Middleton, WI), with an argon-ion laser coupled to a Diaphot 200 inverted microscope (Nikon, Inc., Melville, NY) and equipped with a 40ϫ oil-immersion objective (Nikon Plan Fluor, N.A. 1.30) and a 100ϫ oil-immersion objective (Nikon Plan Fluor, N.A. 1.30). Cells labeled with fluorescein were visualized by excitation at ϭ 488 nm using a fluorescein band pass filter and fluorescence emission was detected at ϭ 515-550 nm. Cells labeled with rhodamine red-X were visualized by excitation at ϭ 568 nm light using a rhodamine long pass filter and fluorescence emission was detected at Ͼ 590 nm. The beam was attenuated using a 15-nm or 25-nm dichroic confocal aperture. The exposure time (100 ns) was held constant for all images. Frameaveraged confocal images (256/image) were digitized at 512 ϫ 480 pixels using microcomputer-based imaging software 
Three-Dimensional Image Analysis
Tissue sections were analyzed with a DMRA epifluorescence microscope (Leica, Inc., Deerfield, IL) equipped with a motorized z-stage. Two wavelength z-series at 0.1-m steps were visualized with a 100ϫ oil-immersion objective (Leica HCX PL Fluotar, N.A. 1.30) and digitized images were acquired with Open Lab 3.01 (Improvision, Boston, MA). Fluorescein labeling was visualized by excitation at ϭ 488 nm using a fluorescein band pass filter and fluorescence emission was detected at ϭ 530 nm. Rhodamine labeling was visualized by excitation at ϭ 546 nm using a rhodamine long pass filter and fluorescence emission was detected at ϭ 600 nm. The stacks of digitized images were deconvolved with an iterative 3D restoration program and reconstructed as 3-dimensional volumes using Volocity 1.3R2 (Improvision).
RESULTS
Clinicopathologic Information
The parietal white matter at the level of the trigone was analyzed in 23 human brains, ranging from 18 to 40 postconceptional weeks. Because several of the antibodies that specifically recognize OL precursors (i.e. O4, O1, anti-NG2) fail to work in formalin-fixed or paraffin-embedded tissue, all of the cases in this study were prospectively collected and immersion-fixed in paraformaldehyde (see Materials and Methods). The mean postmortem interval for autopsy cases (n ϭ 15) was 19 Ϯ 7 h. The number of brains according to age group were as follows: 18 to 22 wk (7 brains); 23 to 28 wk (5 brains); 30 to 36 wk (6 brains); 37 to 40 wk (5 brains). The brains were free of PVL or other major malformative or acquired lesions. The causes of death included the following: therapeutic abortion, 6; stillborn, 1; extreme prematurity, 1, congenital heart disease, 2; major noncerebral congenital malformations, 5; respiratory distress, 5, fetal distress at delivery, 2; undetermined, 1.
Relationship of Immature OL Processes to Axons Prior to and During Early Cerebral Myelinogenesis
We first sought to account for the distribution of immature OLs in the parietal white matter, prior to the onset of myelination, by determining their relationship to axons that expressed neurofilament protein. We examined whether axons might form scaffolding along which the immature OLs were aligned. In order to define the relationship of OL processes to axons, we employed immunofluorescent double-labeling for the O4 or O1 antibodies, both of which label immature OLs, and SMI 312, the latter a mixture of antibodies that recognizes phosphorylated epitopes of neurofilament protein in fetal human brain (36) . By 18 wk, a small number of immature OLs were found to be preferentially localized to mid and deep parietal white matter (Fig. 1A) . The majority of these immature OLs were associated with the axon bundles of the optic radiation that labeled with SMI 312 ( Overlay of the images in (A) and (B). Arrows in (B) and (C) delineate the approximate boundaries of the SMI-312-labeled axons in the optic radiation. D: High-power digital overlay, from a case at 20 wk, shows that the processes of an O1-labeled immature OL are randomly oriented relative to axons in the mid-cerebral white matter that were visualized with SMI-312. E, F: An immature OL in the mid cerebral white matter (E) extends a single, very long process (arrows) that is visualized for about 100 m. Note in (F) that the process is oriented parallel to axons. This process made no apparent axonal contacts when it was analyzed in multiple confocal planes of section. G, H: Representative example of an immature OL that elaborates specialized processes that are directed tangentially toward individual axons and that make apparent contact with them (arrowheads). Note in (H) the OL processes that are directed longitudinally along axons (lower arrowheads). I: Higher power detail of OL processes that are longitudinally oriented in close association with individual axons (arrows). C). Despite the close association of many of the immature OLs with the optic radiation, the processes of most of these cells were randomly oriented relative to axons (Fig.  1D ). We also occasionally detected an immature OL that elaborated a very long process that was tangentially directed toward the pial surface (Fig. 1E, F) . These cells were present around mid-gestation and disappeared later in development. Hence, despite their proximity to axons, the processes of immature OLs were mostly oriented at random relative to axons and did not initiate axonal wrapping prior to 30 wk.
The onset of myelination around 30 wk is characterized by a marked expansion in the number of immature OLs in the white matter (14) . At this time, immature OLs were found to elaborate more specialized-appearing processes. These processes were not randomly oriented in the white matter. Rather, they appeared to have a selective orientation toward individual axons that were visualized with SMI 312, and they appeared to initiate contact with these axons (Fig. 1G, H, arrowheads) . Some OLs extended multiple processes preferentially toward a collection of axons (Fig. 1G) . Other OLs extended one or more processes that were oriented longitudinally along a group of axons (Fig. 1H, I )
In order to evaluate the orientation of the processes of immature OLs that appeared to contact axons, we next generated 3-dimensional reconstructions of regions of the optic radiation from a case at 30 wk. Figure 2 shows several orientations of an immature OL at an early stage of axonal contact and wrapping. One process of this cell was found to make multiple points of initial contact with an axon at a point close to the soma ( Fig. 2A , double arrows; Fig. 2C, arrows) . The process did not simply flatten and extend along the axon, but, rather, wrapped around it (Fig. 2B, C, arrowheads) . The process was continuous with a sheath that completely encircled the axon (Fig. 2B, lower arrow) . Interestingly, this early axon sheath was visualized as a series of free-floating puncta of O4-labeling around the axon, in contrast to more mature sheaths where the O4-labeling around the axon was visualized as a continuous tube-like structure (Fig. 3C) . Distal to the axon sheath, the OL process continued to travel along the length of the axon where it was found to contact the axon in multiple planes of view. The points of contact in any give plane were also discontinuous and consistent with the notion that the process wrapped around the axon (Fig. 2D, E) .
Morphological Relationship between Immature OL Processes and Axons
Models of CNS myelination are largely derived from ultrastructural studies and predict that a single OL process wraps a single axon (25, 26) . We examined this prediction with confocal laser microscopic studies that defined the morphological relationship of the axon sheath to the OL process when these sheaths first appeared at around 30 wk. The sheaths and the processes of immature OLs were visualized with either the O4 or the O1 antibodies. In agreement with ultrastructural studies, we found that individual OLs commonly generated several sheaths. Interestingly, during the early stages of axon wrapping, the distal end of OL processes divided to form several finger-like projections that were arranged along the longitudinal extent of the sheath (Fig. 3A, C , small arrowheads). We found that immature OLs elaborated several types of distal processes that were closely associated with the sheath: 1) a single OL process divided into a spray of distal processes that were directed toward more than 1 sheath (Fig. 3A, B, arrowheads) ; 2) several processes from a single OL were directed toward a single sheath (Fig. 3C); 3) a single OL process was directed toward multiple sites along a single sheath (Fig. 3D, arrow) . Some of these processes appeared to elaborate finger-like terminal thickenings at the point of approximation with the axon (Fig. 3D, arrowhead) .
We next examined by confocal microscopy whether the sheaths that labeled with the O4 or O1 antibodies, in fact, wrapped axons. To address this question, we performed immunohistochemical double-labeling studies in which we compared the distribution of O4-or O1-labeled sheaths with neurofilament protein-labeled axons in the optic radiation. In cases studied around 30 wk, the number of sheaths in the optic radiation (Fig. 4A) was much lower than the number of axons (Fig. 4B) ; a finding that supported that some axons were wrapped in advance of others. We confirmed that at the onset of myelinogenesis, short segments of axons were initially wrapped by sheaths labeled with the O4 (Fig. 4C ) or O1 antibodies (not shown) and long adjacent sections of the axon were not wrapped.
Role of Immature OLs in the Initiation of Human Myelinogenesis
We first asked what OL stages are involved with the initial phase of myelination. The fact that a low number of immature OLs were present in the white matter for at least 3 months before the onset of myelination raised the question of the role of these cells in myelinogenesis. In 15 cases examined between 18 and 28 wk, immature OLs were present but no sheaths were detected with the O4 or O1 antibodies. Sheaths were first detected with either antibody around 30 wk. Numerous sheaths were restricted to the deep cerebral white matter where they were heavily concentrated in the region of the optic radiation (Fig. 5A) . These sheaths were closely associated with the somata of complex multipolar OLs that were intercalated among them (Fig. 5B) .
In order to determine which stages in the human OL lineage initiated myelination, we performed immunohistochemical double-labeling studies in which the distribution of sheaths that were visualized with the O1 antibody was compared with that of sheaths labeled with a biotinylated O4 antibody (bO4) (see Materials and Methods). There was complete overlap in the labeling of these sheaths and the closely associated OL somata, both of which labeled with the bO4 and O1 antibodies ( The contact with the axon appears to be initiated from a thickened proximal process (double arrow in panel A; upper arrow in panel B) adjacent to the soma (S) and to progress distally along the axon. There are multiple points of contact between the axon and this proximal OL process (arrows, panel C). This OL process continues distally and spirals around the axon (arrowheads, panels B, C) and is continuous with the enlarging sheath that encircles the axon (lower arrow in panel B). Distal to the sheath the OL process continues to course along the surface of the axon (arrows, panels D and E). An apparent axonal varicosity is indicated by the arrowhead in panel (E). This distal OL process makes multiple points of contact with the axon (arrows in panels D, E) many of which show a merging of the green and red channels as yellow. Note that in both the lateral view of the axon in (D) and the top-down view in (E), the OL process makes multiple points of discontinuous contact along the surface of the axon supporting the notion that the distal OL process wraps around the axon as it travels along it. Scale bars: A ϭ 10 m; B ϭ 3 m; C-E ϭ 5 m. D). The O4 and O1 antibodies localized to the sheaths whereas a central core, apparently related to the axon, was unlabeled (Fig. 5E, F) . These studies confirmed that the first sheaths visualized in the white matter around 30 wk derived only from O4ϩO1ϩ immature OLs.
Early Myelinogenesis is Characterized by a Progressive Increase in Labeling for MBP
In order to characterize the sequence of cellular events related to incorporation of MBP into the O4ϩO1ϩ Cases at 30 to 40 wk demonstrate features of the morphological relationship between OL processes and early axon sheaths that were labeled with the O4 antibody and visualized by confocal laser microscopy. Lower power (A) and higher power (B) images of a single proximal OL process that divides to form a spray of distal processes that are directed toward at least 2 sheaths. In (A), the proximal process (arrow) divides into multiple distal processes (arrowheads). These processes are closely associated with 2 separate myelin sheaths or tubules (T). Note that several distal processes are closely associated with the lower sheath. Note also the complexity of the OL process arbor of this cell at this early stage of myelinogenesis. In (B), a proximal OL process divides close to the soma into 2 processes (upper and lower arrowheads) that are closely associated with 2 separate sheaths (arrows). In (C), 2 distinct processes (upper and lower large arrowheads) originate near the OL soma (arrow) and are closely associated with the sheath at multiple points of approximation (small arrowheads). In (D), an OL process elaborates terminal thickenings at the point of association with the sheath (arrowhead). Note that another process (arrow) bifurcates and extends longitudinally along an extended portion of the axon segment. Scale bars: A, C ϭ 10 m; B ϭ 5 m; D ϭ 25 m.
sheath, we first developed a method to co-visualize the O4 or O1 antibodies together with MBP (see Materials and Methods). MBP was optimally visualized in the presence of the detergent Triton X-100, but the detergent markedly reduced the labeling with the O4 or O1 antibodies, due to apparent solubilization of their respective antigens from the sheath. Solubilization of the O4 or O1 antibodies did not occur if these antibodies were fixed in the tissue with paraformaldehyde prior to detergent exposure (see Materials and Methods).
Around 30 wk, when sheaths were first visualized, the majority labeled with the O4 and O1 antibodies ( but not with SMI 99, which recognizes all 3 isoforms of human MBP (Fig. 6B) . We examined whether the lower number of MBP-positive sheaths might be due to decreased binding by the antibody. We tested several standard methods of antigen retrieval (see Materials and Methods) and found no apparent change in the number or distribution of SMI 99 immunoreactive sheaths, relative to those labeled with O4 and O1 (data not shown). However, with increasing gestational age between 30 and 40 wk (n ϭ 8 cases), progressively more sheaths were visualized that labeled for MBP, thereby supporting that the magnitude and distribution of the MBP-labeling was a function of developmental age.
When we employed confocal microscopy to characterize the relationship of the structures labeled with the O4 antibody and those labeled with SMI 99, we found that there was marked heterogeneity in the labeling of sheaths and 3 separate populations were identified: O4ϩMBPϪ, O4ϩMBPϩ, and MBPϩ. Similar results were obtained with the O1 antibody. The majority of the sheaths were strongly labeled with either the O4 and O1 antibodies (Fig. 6C , arrows) or with SMI 99 (Fig. 6C, arrowheads) , and only a small subset of all the sheaths labeled with both the O4 or O1 antibodies and with SMI 99 (Fig. 6D,  E) . That these sheaths were derived from OL precursors was supported by apparent continuity between OL processes and the double-labeled sheath (Fig. 5D, arrows) . There was a characteristic structural relationship to the sheaths that were double-labeled for the O4 or O1 antibodies and SMI 99 (Fig. 6F-H) . The O4 or O1 antibodies appeared to most strongly label the outer portion of the sheath (Fig. 6F) , whereas MBP (Fig. 6G, H ) appeared to be localized to the inner portion of the myelin sheath.
DISCUSSION
Much of the current understanding about early myelinogenesis derives from ultrastructural studies in newborn animals (25, 26, 37, 38) . In contrast to rodents, human myelinogenesis begins in utero and has not been extensively studied at the cellular level, because of a lack of suitable methods to distinguish successive stages in the OL lineage in postmortem fetal human tissue. We thus undertook this study in order to characterize cellular mechanisms of fetal myelinogenesis relevant to such clinically important disorders of cerebral myelination as PVL. Prior light microscopic studies employed mature OL markers (e.g. MBP) to visualize the progressive changes that occur in the myelin sheath during early myelinogenesis in human fetal spinal cord (10, 11, 29) or in the neonatal rat (39, 40) . In the present study we characterized the initial cellular events that occur when the processes of human immature OLs initiate contact with axons and generate axonal sheaths that have not yet incorporated MBP. 5 . Distribution, morphology, and immunohistochemical phenotype of early axon sheaths in the optic radiation. Fluorescent photomicrographs in (A) and (B) and confocal digitized images in (C-F). A low power image in (A), from a case at 30 wk, shows a region of the optic radiation of advanced myelination where O4-labeled sheaths were extensively visualized. In (B), a region of early myelination is seen where scattered sheaths (arrowheads) are closely associated with OL somata (arrows). Note that these OL somata have generated short segments of sheaths and still retain a complex arbor of processes. By contrast, in (C, D) the cells display a reduction in the OL process arbor in a region of advanced myelination. ''Premyelin'' sheaths and somata (arrows) were double-labeled with a biotinylated O4 antibody (C, E) and with the O1 antibody (D, F). In (E) and (F), a higher power detail of the sheaths suggests that they form a loosely wrapped hollow-appearing structure that surrounds an axon. In vitro studies of OL lineage progression in rodent and human cells have demonstrated a clear dissociation between the timing of OL maturation and the expression of mature myelin-associated proteins that is regulated by distinct combinations of growth factors (13, 41, 42) . Our results support the concept that the timing of human OL differentiation and myelination are under independent control in vivo. Although results from avian and rodent studies support that galactocerebroside-positivity correlates with rapid commitment of immature OLs to a myelinating phenotype, (21, 23, 43, 44) , our results indicate that in fetal human cerebral white matter the differentiation to an immature OL is necessary but not sufficient to commit the cell to myelinate. We found that, like the rat, human myelinogenesis is also stage-specific and initiated only by the O1ϩ immature OL (21) . However, human immature OLs were preferentially associated with the optic radiation by at least 18 wk (Fig. 1A-C) , but the first axon sheaths were not detected until around 30 wk. This finding correlates with our prior observations that during human parietal white matter development, the percentage of immature OLs in the cerebral white matter remains relatively stable until around 30 wk, at which time the number of immature OLs increases markedly (14) . Interestingly, the immature OL in vitro is a transitional OL stage that is observed when late OL progenitors are driven to a mature OL in the presence of appropriate trophic factors (32, 45, 46) . Hence, one explanation for the prolonged arrest of human immature OLs in a premyelinating state prior to 30 wk may be the lack of appropriate extrinsic factors that switch immature OLs to a myelinating phenotype. Axon-dependent mechanisms appear to play an important role in the timing of the immature OL commitment to myelinogenesis (47, 48) . Release of trophic factors from axons, for example, determines the ultimate number of OLs in the rodent optic nerve (49) .
The biological significance of the immature OLs in the optic radiation by mid-gestation is unclear since these cells do not produce myelin. One explanation is that the accelerated maturation of the OL lineage in the optic radiation occurs in response to maturation of the visual system. One measure of the maturation of the visual cortex and optic radiation in the premature infant is the visual evoked response, which can be detected around midgestation, as early as 22 to 24 wk (12) . Our data thus support that the emergence of this response occurs prior to the onset of myelination of the optic radiation and raises the possibility that functional maturation of the visual system near mid-gestation might account for the predilection for early OL maturation in association with the optic radiation. Interestingly, we detected the onset of myelination of the optic radiation around 30 wk, which coincides with the evolution of the visual evoked response between 32 and 35 wk to the principal wave forms that closely resemble the mature response that is observed by 39 wk.
Consistent with these observations, there was no apparent contact between immature OLs and axons prior to the onset of myelinogenesis (Fig. 7A) . The initiation of myelinogenesis around 30 wk was preceded by the appearance of a subset of specialized OL processes that we designated ''pioneer'' processes that contact and wrap around axons (Fig. 7B) . The axonal signals that may stimulate such OL processes to grow toward and contact CNS axons are poorly understood (50) . Our results are consistent with a role for these processes as the initiation sites for myelination. It is possible that these initial contact sites serve to anchor the OL before it initiates the spiral wrapping of myelin along the same or other axon segments. These processes appear to be the antecedent to the ''initiator sheaths'' observed during early myelinogenesis in the neonatal rat (40) .
Our results, derived from confocal laser microscopy, suggest that myelinogenesis is more complex than previously proposed from ultrastructural studies (25, 41) . These studies support the finding that a single OL process myelinates a single axon segment. Although we found a one-to-one relationship between some OL processes and axon segments, many OL processes were found to divide and ensheath more than 1 axon (Fig. 7C) . Hence, it appears that a single OL process can affect axonal conduction along more than 1 axon segment. Ultrastructural studies that employed mature myelin markers such as MBP support the finding that the OL process initially expands into a continuous paddle-like sheet of myelin (25, 26) . Our data, derived from markers of immature OLs, suggest that in the course of this process OL processes divide distally into an array of finer processes that are continuous with the myelin sheath (Fig. 7C) .
Studies that employed the ''shiverer'' mutant phenotype, which results from a large deletion of the MBP gene, support that MBP expression is involved both in axon wrapping and in myelin compaction (51) . Ultrastructural studies that employed shiverer mice bred to express varying levels of MBP demonstrated that that the Other processes are oriented randomly and do not make axonal contact. The fate of these latter processes was not studied. They may await later molecular cues to initiate myelination or, they may die back due to failure to compete for axon segments. C: Initiation of axon wrapping. The distal end of the OL processes divide to form several finger-like projections that are arranged along the longitudinal extent of the axon sheath. These distal processes appear to be continuous with the sheath and are the sites at which the growing sheath is generated. Note that process ''a'' makes contact with a single axon segment whereas a proximal portion of process ''b'' divides to contact 2 separate axon segments. OLs ensheath the axon with a premyelin sheath that is composed of glycolipid-rich membranes that label with the O4 and O1 antibodies but not MBP. 2) Transitional Sheath: We found that MBP labeling was restricted to the inner portion of the transitional sheath. We predict that incorporation of MBP into the transitional sheath will result in the onset of myelin compaction. Since the labeling of these sheaths with the O4 and O1 antibodies was restricted to the outer portion of the sheath, our interpretation is that these antibodies label the outer tongue of the growing myelin sheath. Hence, we predict that the outer tongue is still ''premyelin'' that has not yet incorporated MBP. 3) Myelin Sheath: The myelin sheath is fully compacted and MBP is inserted throughout the mature myelin sheath. The lack of labeling by O4 or O1 is related to decreased penetration of the compacted myelin sheath by these antibodies rather than a loss of the antigens recognized by these antibodies. For example, galactocerebroside sulfate (sulfatide) binds the O1 antibody and can be detected by thin layer chromatography several months after birth (9) . degree of myelin compaction in the rat optic nerve correlated with both the expression level and the amount of MBP (31) . Human ultrastructural studies are lacking to confirm that the timing and degree of myelin compaction corresponds with the incorporation of MBP into the myelin sheath during fetal cerebral white matter development. Our results predict that a variable degree of myelin compaction would be detected within a regional population of fetal early myelinating axons. Although MBP can be detected in the cytoplasm of human OL precursors before the onset of myelination (27, 28) , the earliest sheaths that we detected around 30 wk did not contain MBP but were rich in glycoconjugates that bind the O4 and O1 antibodies. Regionally, we found that axons are at different stages of wrapping-some are invested with a premyelin sheath whereas others are wrapped by a myelin sheath that labels for MBP. The latter is consistent with a more advanced stage of wrapping that involves myelin compaction. We, thus, propose the concept of the O4, O1-positive, MBP-negative ''premyelin'' sheath that precedes the incorporation of MBP to generate mature compact myelin. The identification of premyelin sheaths in vivo is consistent with earlier in vitro studies that found that immature OLs generate O4, O1-positive, MBP-negative galactolipid-rich sheets that precede the insertion of MBP into mature myelin-like sheets (32) .
We conclude that human myelinogenesis is characterized by 3 distinct phases (Fig. 8) . We have confirmed in the neonatal rat that these 3 phases of myelinogenesis also occur (Back and Luo, unpublished observations). Our findings were mostly facilitated by using the O4 and O1 antibodies in combination with antibodies against MBP in order to visualize axon sheaths at earlier stages of axon wrapping than was previously studied in rodents. Prior studies in the rat were restricted to the localization of MBP and thus characterized early events in myelinogenesis at a later stage than the present study (40) . In the rat, a marked reduction in the OL process arbor was found to accompany the progressive remodeling of the mature MBP-positive myelin sheath. Our data indicate that during the initial phase of sheath formation, axons are wrapped by premyelin generated by immature OLs that retain a complex OL process arbor. The OL process arbor is subsequently reduced as myelinogenesis progresses. During this phase, we also detected considerable variation in the number of premyelin sheaths in the periventricular white matter. The basis for the selective early myelination of some axons but not others within a fiber tract is not known but may be related to neuronal activitydependent mechanisms (52, 53) Our data support a transitional phase of myelinogenesis (Fig. 7) where the O4ϩO1ϩ premyelin sheath begins to incorporate MBP. We observed a small number of axons where only the external portion of the sheath labeled with the O4 and O1 antibodies. We speculate that at this phase the sheath is still enlarging and the O4ϩO1ϩ external portion of the sheath may be the outer cytoplasmic tongue of the sheath, whereas the inner MBPϩ portion of the sheath is compact myelin. In fact, studies of intracellular trafficking of MBP found that the cellular localization of MBP mRNAs changes during OL maturation. Prior to active myelination, certain MBP isoforms localize to the cell body and nucleus and later are selectively transported to intracellular regions of myelin compaction (54) (55) (56) (57) . Hence, the mechanism for spatial segregation of MBP mRNAs to the myelin sheath becomes operative, as OLs become mature myelinating cells. Our results thus support that MBP is inserted after the generation of a rudimentary premyelin sheath, and provide further support for the concept that compact myelin is generated after the insertion of MBP into the premyelin sheath.
Recent clinical studies of newborns between 24 and 40 wk postconception with diffusion tensor magnetic resonance imaging showed changes in water diffusion that correlate with our morphological data. Thus, in central white matter, relative anisotropy, a measure of preferred directionality of water parallel to fiber tracts, increases markedly from 28 to 40 wk (58) . This increase in anisotropic diffusion occurred in parallel with a decline in overall water diffusion, as measured by the apparent diffusion coefficient. This combination of findings implies restriction of diffusion perpendicular to fiber tracts and could relate to the ensheathment of fibers by OL processes, as shown in our study.
A central question related to the pathogenesis of PVL is whether susceptibility of certain stages of the OL lineage to hypoxia-ischemia might contribute to the disruption in myelination that characterizes this disorder (59) . We have found that mature MBP-positive OLs exhibit increased resistance to death induced by oxidative stress in vitro, whereas late OL progenitors (preOLs) are extremely susceptible (46) . We recently demonstrated that the periventricular parietal white matter, a region commonly susceptible to PVL, undergoes active myelination during the period when the peak incidence of PVL declines (14) . Interestingly, the periventricular white matter is initially populated by numerous MBP-negative premyelin sheaths and the number of MBP-positive myelin sheaths increases as term gestation approaches. Further studies are needed to evaluate when during the course of early myelinogenesis the resistance of the OL lineage to injury may occur and what relationship this resistance may have to the susceptibility of the cerebral white matter to PVL.
